SE7907621L - Etomidat-haltiga kompositioner - Google Patents

Etomidat-haltiga kompositioner

Info

Publication number
SE7907621L
SE7907621L SE7907621A SE7907621A SE7907621L SE 7907621 L SE7907621 L SE 7907621L SE 7907621 A SE7907621 A SE 7907621A SE 7907621 A SE7907621 A SE 7907621A SE 7907621 L SE7907621 L SE 7907621L
Authority
SE
Sweden
Prior art keywords
etomidate
containing compositions
anaesthetics
hydrobromide
phenylethyl
Prior art date
Application number
SE7907621A
Other languages
Unknown language ( )
English (en)
Other versions
SE447961B (sv
Inventor
J Mesens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7907621L publication Critical patent/SE7907621L/sv
Publication of SE447961B publication Critical patent/SE447961B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SE7907621A 1978-09-14 1979-09-13 Stabil, etomidathaltig infusionsvetska for intravenos administrering SE447961B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94223678A 1978-09-14 1978-09-14

Publications (2)

Publication Number Publication Date
SE7907621L true SE7907621L (sv) 1980-03-15
SE447961B SE447961B (sv) 1987-01-12

Family

ID=25477775

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7907621A SE447961B (sv) 1978-09-14 1979-09-13 Stabil, etomidathaltig infusionsvetska for intravenos administrering

Country Status (19)

Country Link
US (1) US4289783A (sv)
JP (1) JPS5547858A (sv)
BE (1) BE878709A (sv)
CA (1) CA1140048A (sv)
CH (1) CH651752A5 (sv)
CY (1) CY1254A (sv)
DE (1) DE2937290A1 (sv)
DK (1) DK154926C (sv)
ES (1) ES484160A1 (sv)
FR (1) FR2435945A1 (sv)
GB (1) GB2029700B (sv)
GR (1) GR64915B (sv)
HK (1) HK80984A (sv)
HU (1) HU179989B (sv)
IE (1) IE48689B1 (sv)
IT (1) IT1120537B (sv)
KE (1) KE3426A (sv)
NL (1) NL7906835A (sv)
SE (1) SE447961B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225045A (en) * 1987-07-01 1990-06-26 Janssen Pharmaceutica Nv Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
WO2008112641A2 (en) * 2007-03-09 2008-09-18 New York University Methods and compositions for treating thalamocortical dysrhythmia
JP5763342B2 (ja) 2007-12-20 2015-08-12 アカリクス アクティーゼルスカブ 音響信号を測定するための接着式パッチ
JP5580287B2 (ja) * 2008-03-31 2014-08-27 ザ ジェネラル ホスピタル コーポレイション 改善された薬物速度論的および薬力学的特性を有するエトミデート類似体
CA2767112C (en) 2009-07-10 2018-06-19 The General Hospital Corporation Etomidate analogues that do not inhibit adrenocortical steroid synthesis
ES2617536T3 (es) 2012-01-13 2017-06-19 The General Hospital Corporation Compuestos anestésicos y métodos relacionados de uso
EP3206683A4 (en) 2014-10-16 2018-06-13 The Board of Trustees of the Leland Stanford Junior University Novel methods, compounds, and compositions for anesthesia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354173A (en) * 1964-04-16 1967-11-21 Janssen Pharmaceutica Nv Imidazole carboxylates

Also Published As

Publication number Publication date
GB2029700A (en) 1980-03-26
DK154926C (da) 1989-05-29
IE48689B1 (en) 1985-04-17
DE2937290A1 (de) 1980-04-03
IE791741L (en) 1980-03-14
CH651752A5 (de) 1985-10-15
NL7906835A (nl) 1980-03-18
CY1254A (en) 1984-08-31
DK154926B (da) 1989-01-09
HU179989B (en) 1983-01-28
IT1120537B (it) 1986-03-26
JPS5547858A (en) 1980-04-05
GR64915B (en) 1980-06-09
FR2435945B1 (sv) 1983-02-25
SE447961B (sv) 1987-01-12
JPH0214058B2 (sv) 1990-04-06
KE3426A (en) 1984-08-10
IT7950093A0 (it) 1979-08-23
CA1140048A (en) 1983-01-25
BE878709A (nl) 1980-03-11
GB2029700B (en) 1983-03-30
DK384379A (da) 1980-03-15
FR2435945A1 (fr) 1980-04-11
ES484160A1 (es) 1980-10-01
HK80984A (en) 1984-11-25
US4289783A (en) 1981-09-15

Similar Documents

Publication Publication Date Title
MX9203239A (es) Derivados de 1-(dihidroxifenil)-2-amino-etanol y composiciones farmaceuticas que los contienen.
FR2440360A1 (fr) Nouveaux derives de 4-((3,4-dialcoxyphenyl)-alkyl)-2-imidazolidinones et leur procede de preparation et medicaments les contenant
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2372810A1 (fr) Nouvelles aminoalcoylimidazolidinones, procedes pour leur preparation et leur utilisation en tant que medicaments
ES434829A1 (es) Procedimiento para la preparacion de derivados de 1-(3-( naft-1-il-oxi)2-hidroxipropil)-piperazina.
BE902897A (fr) Derives 3-aminopropoxyaryliques, leur preparation leur application comme medicaments et compositions pharmaceutiques les contenant
DK92781A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
SE7907621L (sv) Etomidat-haltiga kompositioner
FR2370732A1 (fr) Derives polysubstitues de la piperidine, leurs procedes de preparation et leur application en tant que medicaments
NO870560L (no) Nytt farmasoeytisk preparat.
KR870007118A (ko) 광학적으로 순수한 화합물 및 그의 제조 방법
GB1087243A (en) Improvements in or relating to naphthalene derivatives and the manufacture thereof
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
ES340591A1 (es) Procedimiento para preparar derivados de pirrol.
EP0086416A3 (de) Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2391191A1 (fr) Nouveaux composes polypeptidiques, lyeptidiques, leur preparation et leur application comme medicaments
ATE21905T1 (de) Nitrosoharnstoff-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
FR2400017A1 (fr) Nouveaux acides 2-pyridyl- et 2-pyrimidylaminobenzoiques, leur preparation et leur utilisation en tant que medicaments
FR2449680A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
GB979680A (en) Pharmaceutical compositions containing esters of quaternary atropinium salts
ES364717A1 (es) Procedimiento para la preparacion de nuevos derivados de bencensulfonamida.
ES481936A2 (es) Mejoras introducidas en la patente principal: procedimiento para la obtencion de compuestos oxotio.
SE8303012D0 (sv) Farmaceutisk komposition
FR2457291A1 (fr) Nouveaux derives de la pyrido(3,2-e)-as-triazine, leur procede de preparation et medicaments les contenant

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7907621-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907621-2

Format of ref document f/p: F